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Abstract. The efficacy of radiation therapy depends strongly
on tumor oxygenation during irradiation. However, current
techniques to measure this parameter in vivo do not facilitate
routine monitoring in patients. Herein, we demonstrate a non-
invasive method for tomographic imaging of oxygen
partial pressure (pO2) in deep tissue using the phospho-
rescence decay of an oxygen-sensitive probe excited by
Čerenkov radiation induced by external beam radiotherapy.
Tissue-simulating scattering phantoms (60 mm diameter
with a 20 mm anomaly) containing platinum(II)-G4 (PtG4), a
dendritic porphyrin-based phosphor, whose phosphorescence
is quenched in the presence of oxygen, were irradiated with a
clinical linear accelerator. The emitted phosphorescence was
measured at various positions on the phantom boundary using
a spectrograph coupled to an intensified charge-coupled
device (ICCD). At each position, PtG4 phosphorescence
decay curves were measured by synchronizing the ICCD to
the linear accelerator pulses. Tomographic images of phos-
phorescence yield and lifetime were recovered for phantoms
with homogenous PtG4 concentrations and heterogeneous
pO2. Since PtG4 lifetime is strongly and predictably depen-
dent on pO2 through the Stern-Volmer relationship, tomo-
graphic images of pO2 were also reported, and showed
excellent agreement with independent oxygenation measure-
ments. Translating this approach to the clinic could facilitate
direct sensing of pO2 during radiotherapy. © The Authors. Published
by SPIE under a Creative Commons Attribution 3.0 Unported License. Distribution or
reproduction of this work in whole or in part requires full attribution of the original
publication, including its DOI. [DOI: 10.1117/1.JBO.18.5.050503]
Keywords: Čerenkov; phosphorescence; optics tomography; oxygen par-
tial pressure; LINAC; time domain gating; external beam radiotherapy.
Paper 130023LR received Jan. 16, 2013; revised manuscript received
Apr. 3, 2013; accepted for publication Apr. 9, 2013; published online
May 3, 2013.
Tissue oxygenation is a major factor influencing the success or
failure of radiation therapy.1 Thus, techniques for measuring
tumor partial pressure of oxygen (pO2) during the daily fractions
of radiation therapy given to patients could be extremely useful
for tuning treatment conditions and monitoring therapeutic out-
come. However, most methods to measure pO2 in tissue require
invasive instruments2 and thus are difficult to repeat daily and
are sensitive to the high microscopic heterogeneity of pO2 in
tumors.3 An alternative, noninvasive imaging approach using
oxygen-dependent quenching of phosphorescence has been
shown to provide accurate images of pO2 in tumor tissues in
planar4 and tomographic5 imaging geometries. The phosphores-
cence lifetime of these probes is a robust and sensitive indicator
of pO2 in the environment. Applying this noninvasive approach
during radiation therapy could enable monitoring of tissue oxy-
genation during the entire course of treatment, allowing assess-
ment and dose optimization throughout the regimen.
The occurrence of Čerenkov radiation in tissue during exter-
nal beam radiotherapy (EBRT) has been demonstrated in several
recent papers.6–7 Measuring this emission, as well as secondary
luminescence of a fluorophore or phosphor excited by the
Čerenkov radiation, i.e., Čerenkov radiation excited lumines-
cence (CREL), has potential for monitoring a variety of func-
tional parameters during radiation therapy. Previously, we
demonstrated that phosphorescence of a near-infrared (NIR)
oxygen-sensitive probe [platinum(II)-G4, PtG4]7,8 can be
excited by Čerenkov emission and measured EBRT in tissue
phantoms7 in a point-probe geometry. Coupling this measure-
ment approach with a tomographic imaging modality would
facilitate volumetric assessment of tissue oxygenation and pro-
vide more accurate quantification of these parameters in deep
tissues. In this letter, we investigate the ability to recover tomo-
graphic images of CREL-induced phosphorescence yield in a
variety of phantom configurations and oxygenations states, and
examine the feasibility of CREL tomography to recover images
of pO2 from time-resolved phosphorescence measurements.
The experimental configuration is shown in Fig. 1(a). The
external beam irradiator was a Varian Clinic 2100CD linear
accelerator (LINAC). In this study, the LINAC was set to irra-
diate the phantom with a 4-cm-square gamma photon beam with
energy of 6 MV and a dose rate of 600 MU∕min. A 60-mm-
diameter cylindrical tissue-simulating phantom was positioned
on the treatment bed 100 cm from the LINAC head. The phan-
tom contained a 20-mm-diameter cylindrical anomaly region to
simulate tumor tissue. Both the background and anomaly were
filled with 1% v∕v intralipid emulsion in water to mimic tissue
properties for both external beam radiation and optical photon
propagation. In addition to the water/intralipid solution, PtG4,
the oxygen-sensitive phosphor, was added to the background
and anomaly regions of the phantom. Oxygen quenches the
phosphorescence emission and lengthens the phosphorescence
lifetime of this probe in a well-defined way, making PtG4 a reli-
able reporter of pO2. Four combinations of PtG4 contrast and
oxygenation states were used, as tabulated in Fig. 2.
Oxygenation in the anomaly was controlled using the glucose/
glucose oxidase/catalase system. Reference values for the PtG4
phosphorescence lifetime in deoxygenated and oxygenated
environments were measured independently using a frequency-
domain phosphorometer.9
Optical measurements were acquired with a gated Princeton
Instruments PI-MAX3 ICCD attached to an Acton Research
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Insight spectrograph positioned outside the treatment room. The
ICCD was cooled to −25°C and the intensifier set to the maxi-
mum gain. Light emitted from the phantom was coupled to the
spectrometer through a fiber bundle composed of nineteen 200-
μm silica fibers. Using a gated ICCD enables the system to take
advantage of the pulsed operation of LINACs. Radiation from
the LINAC is delivered in 3.23 μs bursts at a repetition rate of
200 Hz. By synchronizing the ICCD with a trigger signal from
the LINAC, as described previously,7,10 the intensity of CREL at
different time points after each radiation burst can be measured.
This effectively eliminates the contaminating excitation signal,
i.e., the Čerenkov emission itself, and facilitates the measure-
ment of phosphorescence lifetime.
In this study, optical measurements were acquired after the
radiation pulses at time delays between 0 and 200 μs in 4 μs
increments, with a gate width of 500 μs. To improve signal-
to-noise, 100 spectra were acquired at each time delay and
summed up. Background measurements were also acquired and
subtracted from the spectra. To produce a full tomographic data
set, this process was repeated (sequentially) for 16 positions of
the fiber bundle around the boundary of the phantom as
represented in Fig. 1(a) and 1(b). Once processed, all spectra
were reduced to a single intensity value suitable for image
reconstruction by integrating 50 nm around the PtG4 phos-
phorescence peak λmax ¼ 772 nm.
Reconstructing images of phosphorescence yield requires an
estimate of the optical excitation field, which in this case is the
Čerenkov field. Accurate modeling of the Čerenkov field can be
accomplished by employing established tools from radiation
oncology. In this study, GAMOS (Geant4-based Architecture
for Medicine-Oriented Simulations)11was used to simulate a
6 MV gamma photon beam, irradiating a 6 × 6 cm2 area with
voxel size 0.5 mm × 0.5 mm × 0.5 mm. A total of 107 primary
particles were launched, and the Čerenkov photons generated
were scored.7 A two-dimensional slice of the field, correspond-
ing to the plane of the optical detectors, was extracted and
adopted as the excitation field for image reconstruction.
The excitation field and processed optical data from the
CREL measurements were combined to recover images of
phosphorescence yield using the fluorescence toolbox in
NIRFAST,12,13 a finite element-based software package for dif-
fusion-based NIR image reconstruction. Images were recovered
using a 60-mm-diameter mesh with 1785 nodes, homogeneous
absorption (μa) and scattering (μ 0s) properties at the excitation
(μ 0ax ¼ 0.033 mm−1, μ 0sx ¼ 1.8 mm−1) and emission (μam ¼
0.002 mm−1, μ 0sm ¼ 1.033 mm−1) wavelengths, and a refrac-
tive index n ¼ 1.327.
To demonstrate external beam-induced CREL tomography
of PtG4, reconstructions were performed in the four phantom
configurations using a time delay of zero with respect to the fall-
ing edge of the radiation burst, which is simply the integrated
phosphorescence decay after the pulse. Images of phosphores-
cence yield and the associated recovered contrast values, calcu-
lated as the mean phosphorescence yield in the known area of
interest divided by the same in the known background area, are
presented in Fig. 2. These results closely follow expected trends,
with the deoxygenated region producing the highest phospho-
rescence yields and contrasts. Particularly encouraging are the
images for phantoms with a constant concentration of PtG4 in
both the background and tumor region. While clear contrast
in phosphorescence yield was observed when the phantom
contained an anoxic tumor region, a nearly homogenous distri-
bution was obtained when both regions were aerated. This dem-
onstrates the strong sensitivity of PtG4 CREL tomography to
PO2, and insensitivity to phosphor concentration.
To examine the feasibility of using this imaging approach for
CREL-based pO2 tomography during radiation therapy, time-
resolved phosphorescence decay images were analyzed for the
phantom with a constant concentration of PtG4 but with an
aerated background and anoxic tumor region, as may be encoun-
tered in vivo. This was accomplished by reconstructing images
for each time delay (from 0 to 200 μs in 4 μs increments) and
fitting each image pixel over time to a single exponential
[Eq. (1)]:






where I0 is the decay initial intensity, It is the intensity measured
for different time points, and τ is the phosphorescence lifetime.
Figure 3(a) shows the phosphorescence decay curves for
pixels in the anoxic and aerated regions, labeled Anomaly and
Background, respectively. The full image of phosphorescence
lifetime is shown in Fig. 3(b). From this image, an image of
pO2 can be recovered directly using the Stern-Volmer equation,





þ kq × pO2; (2)
where τ is phosphorescence lifetime, τ0 is the lifetime in the
absence of oxygen (pO2 ¼ 0, and kq is the oxygen quenching
constant.
The resulting pO2 image is shown in Fig. 3(c). It is note-
worthy that the recovered values of pO2 in the aerated (150 Torr
Fig. 1 (a) Diagram of the measurement system consisting of a linear
accelerator, radiation/optical tissue phantom, and an optical fiber
that couples light from the phantom to a spectrometer with a gated
ICCD synchronized to the radiation bursts of the LINAC. (b) Top view
of the phantom geometry. (c) A two-dimensional cross-section of the
Čerenkov field modeled using Geant4-based architecture for machine-
oriented simulations (GAMOS) and used as the excitation field for phos-
phorescence yield image reconstruction.
Fig. 2 Images of phosphorescence yield from CREL tomography and
associated contrast-to-background values for four PtG4 phantom
configurations.
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approximately) and anoxic regions (0 Torr approximately) are
very close to the true values measured with the reference
probe (reported in Fig. 2). Furthermore, images of pO2 and life-
time provide much higher contrasts than those of phosphores-
cence yield alone, suggesting that the time-dependent approach
is more sensitive and quantitative than imaging based on inten-
sity alone.
These results suggest that CREL-based oxygen tomography
is feasible and that incorporating time-domain analysis can
provide an accurate, robust, and quantitative pO2 imaging
paradigm. The delivery of megavoltage radiotherapy is well
controlled and extensively planned for each subject and
Čerenkov radiation emission will be emitted from targeted
cancer tissues where the charged primary or secondary particles
deposit most of their energy. Thus, CREL will often be excited
in rather deep tissue regions. The emission peaks of the oxygen-
sensitive phosphors are well above 750 nm and thus propagate
readily through most tissues. Standard diffuse optical tomo-
graphy (DOT) systems commonly measure light at these wave-
lengths through 10 cm of tissue without requiring invasive
placement of the optical detectors. As in all forms of optical
NIR tomography, tissue scattering and absorption limit depth
resolution of the disclosed method. However, because of the
relatively slow time scale of triplet emission, phosphorescence
lifetime imaging is less affected by scattering and absorption14
than, e.g., fluorescence lifetime imaging, allowing for more
accurate spatial reconstructions.
The image quality of the tomograms is consistent with typ-
ical DOT images, which are generally of low-spatial resolution.
However, the prevailing trend in DOT is the implementation of
spatial priors from conventional imaging modalities. Since all
patients undergoing EBRT also have extensive co-registered
CT scans used for treatment planning, one could envision using
these data to guide the recovery of pO2. While total acquisition
times reported here were rather long (about 25 s per position),
the instrument and experimental procedure used in this proof-of-
concept study were not optimized for fast acquisition. Small-
diameter fibers and single-channel spectroscopic detection were
all unnecessary constraints limiting acquisition speed. Large-
diameter fiber bundles and coupled to gated wide-area ava-
lanche photodiodes or photomultiplier tubes could improve
light collection efficiency by over 1500-fold without loss of
image quality. Additional improvements in signal intensity
would obtain using more optimized oxygen-sensitive probes
at higher concentrations, as have been studied previously.8
The ability to image pO2 distribution during radiotherapy, as
demonstrated here, would provide unprecedented information
about the tumor micro-environment. This may have a significant
impact in radiotherapy research programs, such as in the devel-
opment of adjuvant and synergistic therapies, and in planning
and tailoring clinical treatment regimens.
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